Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LABT compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
LABT
Lakewood-Amedex Biotherapeutics Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
LABT
Lakewood-Amedex Biotherapeutics Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only LABT
0
None
Shared
0
No disclosed counterparties: LABT.
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
25 more · LLY chain
›
Role chip = supplier or customer
Source: SEC EDGAR
LABT
Lakewood-Amedex Biotherapeutics Inc.
Change
0.54
▲
+182.45%
· post 0.51
Mkt cap
$271,743
Revenue
—
Revenue
—
LLY
ELI Lilly & Co
Change
1,371.32
▼
−3.29%
· post 1,363.77
Closed
Nov 5 '26
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Closed
Nov 5 '26
LABT
Lakewood-Amedex Biotherapeutics Inc.
vs
LLY
ELI Lilly & Co
0.54
▲
+182.45%
post 0.51
Price
1,371.32
▼
−3.29%
post 1,363.77
$271,743
Mkt cap
$1.2T
—
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
LABT
0.54
▲
+182.45%
vs
LLY
1,371.32
▼
−3.29%
Closed
Nov 5 '26